Latest Articles

Publication Date
An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients - Nature

An assisted diagnostic and prognostic model for endometrial cancer using 36 serological markers and clinical variables from 562 patients Nature

Published: Nov. 18, 2025, 2:28 p.m.
The role of mitophagy in female reproductive system diseases: from molecular mechanisms to therapeutic strategies.

Mitophagy is a catabolic mechanism that selectively degrades damaged mitochondria and precisely modulates mitochondrial content, thereby maintaining intracellular homeostasis under stress conditions. To date, most reviews on mitophagy have predominantly …

Published: Nov. 18, 2025, midnight
The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis - Diabetology & Metabolic Syndrome

The association between metabolic syndrome and incidence of endometrial cancer: a meta-analysis Diabetology & Metabolic Syndrome

Published: Nov. 17, 2025, 6:01 p.m.
This Week in Oncology: FDA Approval Shakeups and Key SITC 2025 Data - CancerNetwork

This Week in Oncology: FDA Approval Shakeups and Key SITC 2025 Data CancerNetwork

Published: Nov. 16, 2025, 5:11 p.m.
Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study - Medical Dialogues

Patients with early Endometrial Cancer who don't undergo Hysterectomy have Higher Mortality: Study Medical Dialogues

Published: Nov. 16, 2025, 4:30 p.m.
Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor - Oncodaily

Ane Gerda Zahl Eriksson: SENSOR-LIIFE - Advancing Exercise Research in Endometrial Cancer Survivor Oncodaily

Published: Nov. 16, 2025, 9:57 a.m.
Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 - Oncodaily

Endometrial Cancer Cure Rate: What Patients Need to Know in 2025 Oncodaily

Published: Nov. 16, 2025, 8:17 a.m.
Circulating miRNA as diagnostic tools for gynecological diseases and their applications in biosensor development.

MicroRNAs (miRNAs) have emerged as robust biomarkers for diagnosing and prognosing gynecological diseases due to their disease-specific expression and remarkable stability in body fluids. Despite the inherent instability of RNA …

Published: Nov. 15, 2025, midnight
FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer - Indian Pharma Post

FDA approves Promega’s OncoMate test to guide personalised treatment for endometrial cancer Indian Pharma Post

Published: Nov. 14, 2025, 3:26 p.m.
‘I was rushed to hospital with sepsis after years of crippling pain – doctors even feared it could be cancer before discovering the real cause’ - needtoknow.co.uk

‘I was rushed to hospital with sepsis after years of crippling pain – doctors even feared it could be cancer before discovering the real cause’ needtoknow.co.uk

Published: Nov. 14, 2025, 9:26 a.m.
Link copied to clipboard!
Subscribe to Our Newsletter

Stay updated with our latest articles!